In the rush to get Chinese companies onto U.S. markets, Huakang 'David' Zhou was in the thick of it.
在帮助中国公司赴美上市的热浪中,周华康(Huakang "David" Zhou)可算是个“弄潮儿。
Mr. Zhou, who is a consultant, and his son Peter Dong Zhou, a former broker, helped numerous Chinese companies go public in the U.S., according to Securities and Exchange Commission documents. The elder Mr. Zhou's New Jersey firm, Warner Technology & Investment Corp., 'provides full services' for public listing, its website says, from business planning to legal advice.
美国证券交易委员会(U.S. Securities and Exchange Commission,简称SEC)的文件显示,身为咨询师的周华康与其曾为经纪人的儿子Peter Dong Zhou协助若干中国企业赴美上市。周华康旗下华纳国际投资集团(Warner Technology & Investment Corp.)在官网上说,为企业上市提供从业务规划到法律意见等全方位服务。该集团在美国新泽西州注册成立。
But some companies Huakang Zhou worked with didn't turned out well for investors. Earlier this year, the New York Stock Exchange delisted American Oriental Bioengineering Inc., which he helped with a 'reverse merger' that brought it to the U.S., after AOB said its auditors found 'inconsistencies' during its audit. Last year, Nasdaq delisted Advanced Battery Technologies Inc., another Zhou-assisted reverse merger, because the company wouldn't comply with toughened procedures for confirming its bank accounts.
【中概股“看门人”受调查】相关文章:
★ 清明节双语介绍
最新
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15